ArticleJournal for immunotherapy of cancer2021

Self-assembly nanovaccine containing TLR7/8 agonist and STAT3 inhibitor enhances tumor immunotherapy by augmenting tumor-specific immune response.

Lele Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.